查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1912812

无菌采血管市场按添加剂类型、材质、产品类型、最终用户、应用和分销管道划分－2026-2032年全球预测

Sterile Blood Collection Tube Market by Additive Type, Material, Product Type, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

无菌采血管市场预计到 2025 年将达到 15 亿美元，到 2026 年将成长到 15.8 亿美元，到 2032 年将达到 26.8 亿美元，复合年增长率为 8.64%。

关键市场统计数据
基准年 2025 15亿美元
预计年份：2026年 15.8亿美元
预测年份 2032 26.8亿美元
复合年增长率 (%) 8.64%

本文简要介绍了无菌采血管对诊断信心、临床工作流程、法规遵循和供应商关係的影响。

无菌采血管是临床诊断中的基础医疗设备，为从常规检测到高阶分子检测的所有诊断方法奠定了基础。它们能够实现准确的检体采集、分析物的保存和安全运输，这些因素共同影响诊断的准确性和后续的临床决策。近年来，赋形剂化学、管材和密封技术的不断改进降低了分析前变异性，提高了检体完整性；同时，监管机构对可追溯性和污染控制的日益重视也推动了整个医疗保健系统采购规范的提高。

添加剂化学、自动化准备、日益严格的法规和分散式检查等变革性变化正在重新定义供应商和产品的优先事项。

无菌采血管市场格局正在发生变化，技术、监管和工作流程这三大力量相互交织，重塑竞争格局。首先，添加剂化学和材料科学的创新正在拓展采血管的功能，延长分析物的稳定性，提高与自动化平台的兼容性，并减少对新兴检测方法的干扰。这些技术变革并非孤立存在，而是与检查室自动化的发展趋势相互作用，推动着采血管形状和管盖设计朝着更适合机器人操作和条码追踪的方向发展。

分析2025年关税调整对临床供应链采购实务、价格透明度、供应商选择标准和紧急时应对计画的影响

美国近期关税政策的变化增加了医疗耗材（包括无菌采血管）筹资策略的复杂性。关税调整影响了供应商选择、价格谈判和采购区域，迫使采购方重新评估其总到岸成本，并寻求替代方案以确保供应的连续性。各机构越来越多地将关税情景纳入供应商资质审核和合约设计中，并要求供应商就原产国、成本转嫁机制以及保护最终用户免受成本突然上涨影响的缓解措施做出明确解释。

透过对辅料类型、材料、产品形式、最终用户、临床应用和分销管道进行综合細項分析，为相关人员提供策略启示。

透过明确无菌采血管市场的功能和商业性需求，市场细分为製造商、采购商和实验室管理人员提供了策略选择。根据添加剂类型，相关人员必须权衡柠檬酸盐、EDTA、肝素和无添加剂采血管之间的临床相容性，以确保检测的完整性，并符合检测项目和抗凝血要求。关于材料（玻璃或塑胶）的选择需要在分析物稳定性、破损风险和环境因素之间进行权衡。虽然塑胶具有更高的耐用性，但对于某些检查室工作流程和分析物相互作用，玻璃可能是更好选择。

重点区域趋势：阐述美洲、欧洲、中东和非洲以及亚太地区的采购惯例、法规结构和供应链策略有何不同。

区域趋势正深刻影响产品需求、监管互动和供应链设计，导致各主要区域的优先事项出现差异。在美洲，采购决策越来越重视营运弹性、与集中式检查室自动化系统的兼容性以及支援高通量诊断工作流程的解决方案。希望进入区域网路的製造商必须提供可靠的检验数据和快速的供货能力，以满足大规模医疗系统和参考检查室的需求。

主要企业层面洞察，包括差异化、验证投资、通路伙伴关係和供应链韧性，这些因素共同塑造了临床采购领域的竞争优势。

无菌采血管市场的竞争特征在于产品差异化、品质保证和操作可靠性之间的平衡。那些投资于额外验证、与主流分析仪器平台相容性测试以及完善品管系统的公司，能够降低检查室风险并简化产品与现有工作流程的集成，从而脱颖而出。对生产认证、可追溯性系统和文件包的策略性投资，能够增强买家信心并促进机构核准。

为製造商和供应商提供实用建议，结合检验、模组化交付、柔性製造、混合分销和服务质量，以加速其采用。

产业领导者应优先考虑一系列战术性和策略性倡议，以确保供应的连续性，同时使产品功能与检查室需求相符。首先，透过投资检验与目标侦测项目和自动化平台直接相关的辅料和材料，并向采购和临床团队提供便利的检验数据，来缩短审批週期。其次，开发模组化产品线，以满足从门诊诊所到大型医院等不同终端用户的需求，并使销售团队能够提供客製化的核准提案，而不是单一的、一刀切的解决方案。

采用透明的调查方法，包括访谈、文献综述、资料三角验证、细分设计以及对限制的考量，以确保研究结果的可靠性和可操作性。

本分析的调查方法融合了定性和定量方法，以确保证据基础的一致性和可靠性。主要资料收集包括对实验室技术人员、采购人员和临床终端使用者进行结构化访谈，以了解实际应用中的效能优先事项、验证要求和采购行为。次要研究则查阅了监管指南、行业标准和技术文献，以阐明辅料化学、材料特性和分析设备相容性要求。

简洁的结论总结了技术、营运和采购的优先事项如何相互交织，最终决定临床应用和供应商的长期成功。

无菌采血管是诊断价值链中的关键转折点，相对较小的产品改进即可显着提高临床可靠性和检查室效率。赋形剂的化学性质、材料选择和装置几何形状的相互作用决定了采血管在包括生物化学、凝血、血液学和血清学在内的各种应用中的表现。同时，分销管道和区域法规环境也会影响新规格采血管的推广速度以及供应商价值提案的定位。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依添加剂类型分類的无菌采血管市场

  • 柠檬酸盐
  • EDTA
  • 肝素
  • 不含添加剂

9. 依材料分類的无菌采血管市场

  • 玻璃
  • 塑胶

第十章 无菌采血管市场（依产品类型划分）

  • 非真空型
  • 真空型

第十一章 依最终用户分類的无菌采血管市场

  • 门诊部
  • 血库
  • 诊断中心
  • 医院

第十二章 无菌采血管市场（依应用领域划分）

  • 生物化学
  • 凝血
  • 血液学
  • 血清学

13. 按分销管道分類的无菌采血管市场

  • 直销
  • 经销商
  • 电子商务
    • 公司网站
    • 网路市集

14. 按地区分類的无菌采血管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 按组别分類的无菌采血管市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国无菌采血管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章美国无菌采血管市场

第十八章 中国无菌采血管市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma, Inc.
  • Becton, Dickinson and Company
  • Biosigma SpA
  • Cardinal Health, Inc.
  • CML Biotech（P）Ltd.
  • DWK Life Sciences GmbH
  • FL Medical Srl
  • Greiner Bio-One International GmbH
  • Improve Medical Technology Co., Ltd.
  • Narang Medical Limited
  • Nipro Medical Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13AB3

The Sterile Blood Collection Tube Market was valued at USD 1.50 billion in 2025 and is projected to grow to USD 1.58 billion in 2026, with a CAGR of 8.64%, reaching USD 2.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.50 billion
Estimated Year [2026] USD 1.58 billion
Forecast Year [2032] USD 2.68 billion
CAGR (%) 8.64%

A concise introduction highlighting how sterile blood collection tubes influence diagnostic reliability, clinical workflows, regulatory compliance, and supplier relationships

Sterile blood collection tubes are foundational devices in clinical diagnostics, underpinning everything from routine laboratory tests to high-complexity molecular assays. They enable accurate specimen collection, preservation of analytes, and safe transport, which collectively influence diagnostic fidelity and downstream clinical decisions. Over recent years, incremental improvements in additive chemistries, tube materials, and closure technologies have reduced pre-analytical variability and improved sample integrity, while regulatory emphasis on traceability and contamination control has elevated procurement specifications across health systems.

Clinicians, laboratorians, and procurement teams increasingly view collection devices not as commoditized disposables but as integral components of the diagnostic workflow that materially affect turnaround times, assay compatibility, and patient safety. This reorientation has prompted closer collaboration between device manufacturers and laboratory systems to validate compatibility with automated analyzers and to ensure additives reliably preserve target analytes. As a result, investment in quality control, supplier qualification, and training has intensified, shaping competitive dynamics. In this context, innovation that demonstrably reduces pre-analytical error or simplifies workflow yields notable clinical and operational value, and organizations that align product development with laboratory needs can strengthen market positioning.

Transformative shifts driven by additive chemistry, automation compatibility, regulatory rigor, and decentralized testing that are redefining supplier and product priorities

The landscape for sterile blood collection tubes is shifting in response to converging technological, regulatory, and workflow forces that reframe competitive priorities. First, innovations in additive chemistry and material science are expanding the functional envelope of tubes, enabling longer analyte stability, enhanced compatibility with automated platforms, and reduced interference with emerging assays. These technological shifts are not isolated; they interact with lab automation trends that favor tube formats and closure designs optimized for robotic handling and barcode traceability.

Concurrently, regulatory frameworks and quality systems demand more rigorous supplier evidence, including validations demonstrating that tubes maintain analyte integrity across expected transit and storage conditions. This creates a higher barrier to entry for new suppliers and steers buyers toward partners who offer robust technical documentation and responsive quality support. In parallel, the growth of decentralized testing and ambulatory care delivery has altered demand patterns, increasing the need for tubes that perform reliably outside traditional hospital laboratory environments. Taken together, these transformative shifts are prompting manufacturers to prioritize validated compatibility, supply chain resilience, and user-centered design to remain competitive and to meet evolving clinical expectations.

Analysis of how 2025 tariff adjustments are reshaping sourcing, pricing transparency, supplier qualification, and contingency planning across clinical supply chains

Recent tariff developments in the United States have introduced additional complexity into procurement strategies for medical consumables, including sterile blood collection tubes. Tariff adjustments influence supplier selection, pricing negotiations, and sourcing geographies, prompting buyers to reassess total landed cost and to seek contingencies that preserve supply continuity. Organizations are increasingly incorporating tariff scenarios into supplier qualification and contract design, requiring suppliers to provide clarity on country of origin, cost pass-through mechanisms, and mitigation plans to shield end users from abrupt cost increases.

In response, manufacturers and distributors have pursued several adaptations. Some have explored nearshoring or regional manufacturing partnerships to reduce exposure to import duties and to shorten lead times, while others have renegotiated long-term contracts that lock in pricing or provide shared risk arrangements. Additionally, stakeholders are paying closer attention to packaging optimization and logistical consolidation to lower per-unit transportation costs and potential tariff burdens. The cumulative effect of these tariff-driven behaviors is a shift toward diversified sourcing strategies, stronger contingency planning, and enhanced transparency across the supply chain to preserve access to validated tubes without compromising quality or laboratory workflows.

Comprehensive segmentation insights linking additive types, materials, product formats, end users, clinical applications, and distribution channels to strategic implications for stakeholders

Segmentation frames strategic choices for manufacturers, purchasers, and laboratory leaders by illuminating distinct functional and commercial needs within the sterile blood collection tube market. Based on additive type, stakeholders must balance clinical compatibility across citrate, EDTA, heparin, and no-additive tubes to ensure assay integrity and to align with test menus and anticoagulation requirements. Decisions around material-glass versus plastic-carry trade-offs between analyte stability, breakage risk, and environmental considerations, with plastic offering improved durability and glass sometimes favored for specific laboratory workflows or analyte interactions.

Product type segmentation, which differentiates non-vacuum from vacuum tubes, intersects with clinical workflow automation and specimen draw protocols; vacuum tubes support standardized draw volumes and are well suited to centralized phlebotomy, while non-vacuum tubes may be preferred in certain point-of-care or manual settings. End user segmentation highlights varying procurement and performance demands across ambulatory clinics, blood banks, diagnostic centers, and hospitals; each setting places different emphasis on throughput, storage, and collection ergonomics. Application segmentation-spanning biochemistry, coagulation, hematology, and serology-requires additive and tube choices calibrated to analyte stability and assay sensitivity. Finally, distribution channel segmentation impacts commercialization strategies, where direct sales, distributors, and e-commerce routes including company websites and online marketplaces each influence margin structure, customer service expectations, and the speed of adoption. Integrating these segmentation lenses enables targeted product development, regulatory dossiers tailored to key use cases, and channel strategies that align with purchaser behavior and clinical priorities.

Key regional dynamics explaining how procurement practices, regulatory frameworks, and supply chain strategies diverge across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics exert a strong influence on product requirements, regulatory interactions, and supply chain design, producing divergent priorities across major geographies. In the Americas, procurement decisions increasingly emphasize operational resilience, compatibility with centralized laboratory automation, and solutions that support high-throughput diagnostic workflows. Manufacturers seeking to penetrate regional networks must demonstrate robust validation data and responsive supply arrangements to satisfy large health systems and reference laboratories.

In Europe, Middle East & Africa, stakeholders navigate a fragmented regulatory and reimbursement landscape, which elevates the importance of localized regulatory expertise and adaptable commercial models. Countries within this region vary in their procurement sophistication, with some markets prioritizing clinical performance and traceability while others emphasize cost containment and distribution reliability. Meanwhile, Asia-Pacific markets exhibit heterogeneity in clinical infrastructure maturity; dynamic demand driven by expanding diagnostic capacity, growing private-sector laboratory networks, and an emphasis on rapid turnaround times creates opportunities for adaptable tube designs and localized manufacturing partnerships. Across regions, factors such as logistics complexity, tariff exposure, and clinical practice patterns shape where firms concentrate investment in regulatory support, manufacturing footprint, and distribution partnerships.

Key company-level insights on differentiation, validation investments, channel partnerships, and supply chain resilience that shape competitive advantage in clinical procurement

Competitive dynamics in the sterile blood collection tube segment are characterized by a balance between product differentiation, quality assurance, and operational reliability. Firms that invest in additive validation, compatibility testing with major analyzer platforms, and robust quality management systems differentiate themselves by reducing laboratory risk and easing integration into established workflows. Strategic investments in manufacturing certifications, traceability systems, and documentation packages increase buyer confidence and facilitate institutional approvals.

Partnerships and channel strategies also shape competitive advantage. Organizations that cultivate strong distributor relationships and provide technical training and post-sale support gain access to broader clinical networks and enhance product adoption. At the same time, direct engagement with large health systems and reference laboratories-through clinical validation studies and joint workflow pilots-can accelerate credentialing and increase switching costs for buyers. Finally, supply chain resilience, including diversified manufacturing footprints and transparent logistics, provides a competitive buffer against disruptions and tariff-related pressures, enabling suppliers to sustain service levels and maintain institutional trust.

Actionable recommendations for manufacturers and suppliers that combine validation, modular offerings, flexible manufacturing, hybrid distribution, and service excellence to drive adoption

Industry leaders should prioritize a set of tactical and strategic initiatives that align product capabilities with laboratory needs while safeguarding supply continuity. First, invest in additive and materials validation that directly maps to target assay panels and automation platforms, and make validation data readily available to procurement and clinical teams to shorten approval cycles. Second, develop modular product offerings that address distinct end-user needs-ranging from ambulatory clinics to high-volume hospitals-so that sales teams can present tailored value propositions rather than a single generic solution.

Third, build flexible manufacturing and logistics strategies that include regional production or toll manufacturing agreements to mitigate tariff exposure and shorten lead times. Fourth, strengthen distribution models by combining direct sales for large accounts with trained distributor networks and e-commerce channels for rapid replenishment and niche market coverage. Fifth, embed post-sale services including training, technical support, and rapid issue escalation to reduce operational friction and increase switching costs. Finally, align sustainability initiatives with product design and packaging to meet evolving procurement criteria and to appeal to institutional purchasers that prioritize environmental stewardship. Together, these actions create a resilient, clinically aligned, and commercially differentiated approach to penetrating and expanding within target markets.

Transparent research methodology describing interviews, literature review, data triangulation, segmentation design, and limitations to ensure credible and actionable insights

The research methodology underpinning this analysis integrated qualitative and quantitative approaches to ensure a coherent and reliable evidence base. Primary data collection included structured interviews with laboratorians, procurement leaders, and clinical end users to capture real-world performance priorities, validation requirements, and purchasing behaviors. Secondary research comprised a review of regulatory guidance, industry standards, and technical literature to contextualize additive chemistry considerations, material properties, and analyzer compatibility requirements.

Data synthesis emphasized cross-validation across sources: interview insights were triangulated with documented regulatory expectations and technical white papers to identify consistent themes and to flag areas of practitioner concern. Segmentation frameworks were developed iteratively, mapping clinical applications, end-user settings, and distribution preferences to product attributes. Where possible, methodological limitations and potential biases were explicitly noted-such as variability in clinical practice across regions and the evolving nature of decentralized testing-which informed cautious interpretation of comparative trends. The resulting methodology balances practitioner perspectives with technical evidence to create actionable insights while maintaining transparency about assumptions and data provenance.

Concise conclusion summarizing how technical, operational, and sourcing priorities converge to determine clinical adoption and long-term supplier success

Sterile blood collection tubes remain a critical inflection point in the diagnostic value chain, where relatively modest product enhancements can produce outsized improvements in clinical reliability and laboratory efficiency. The interplay between additive chemistry, material selection, and device format shapes how tubes perform across diverse applications such as biochemistry, coagulation, hematology, and serology. At the same time, distribution choices and regional regulatory conditions influence how quickly new formats are adopted and how suppliers position their value propositions.

To succeed, stakeholders should align product development, validation strategies, and commercial models with the specific operational contexts of target end users. Prioritizing evidence that demonstrates compatibility with laboratory analyzers, stability under routine handling conditions, and supportive post-sale services will reduce adoption friction. Moreover, attention to supply chain resilience and tariff exposure is essential to maintaining uninterrupted access to validated tubes. Ultimately, manufacturers and purchasers that integrate clinical evidence, operational practicality, and strategic sourcing will be best positioned to deliver and adopt solutions that materially enhance diagnostic workflows and patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sterile Blood Collection Tube Market, by Additive Type

  • 8.1. Citrate
  • 8.2. EDTA
  • 8.3. Heparin
  • 8.4. No Additive

9. Sterile Blood Collection Tube Market, by Material

  • 9.1. Glass
  • 9.2. Plastic

10. Sterile Blood Collection Tube Market, by Product Type

  • 10.1. Non-Vacuum
  • 10.2. Vacuum

11. Sterile Blood Collection Tube Market, by End User

  • 11.1. Ambulatory Clinics
  • 11.2. Blood Banks
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Sterile Blood Collection Tube Market, by Application

  • 12.1. Biochemistry
  • 12.2. Coagulation
  • 12.3. Hematology
  • 12.4. Serology

13. Sterile Blood Collection Tube Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce
    • 13.3.1. Company Website
    • 13.3.2. Online Marketplaces

14. Sterile Blood Collection Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Sterile Blood Collection Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sterile Blood Collection Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Sterile Blood Collection Tube Market

18. China Sterile Blood Collection Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdvaCare Pharma, Inc.
  • 19.6. Becton, Dickinson and Company
  • 19.7. Biosigma S.p.A.
  • 19.8. Cardinal Health, Inc.
  • 19.9. CML Biotech (P) Ltd.
  • 19.10. DWK Life Sciences GmbH
  • 19.11. F.L. Medical Srl
  • 19.12. Greiner Bio-One International GmbH
  • 19.13. Improve Medical Technology Co., Ltd.
  • 19.14. Narang Medical Limited
  • 19.15. Nipro Medical Corporation
  • 19.16. QIAGEN N.V.
  • 19.17. Sarstedt AG & Co. KG
  • 19.18. Sekisui Medical Co., Ltd.
  • 19.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)